These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4383230)

  • 21. [Cardiac effects ofprenylamine and iproveratril in comparison with propanolol, pronethalol an ajmaline].
    Schaumann W; Bodem R; Bartsch W
    Naunyn Schmiedebergs Arch Pharmakol Exp Pathol; 1966; 255(4):328-43. PubMed ID: 4383986
    [No Abstract]   [Full Text] [Related]  

  • 22. The adrenergic-receptor blocking action of verapamil.
    Dorevitch N
    Arch Int Pharmacodyn Ther; 1969 Mar; 178(1):242-50. PubMed ID: 4390919
    [No Abstract]   [Full Text] [Related]  

  • 23. On the cardiac adrenergic blocking action of iproveratril in normal and coronary-ligated dogs.
    Melville KI; Garvey HL; Shister HE
    Rev Can Biol; 1968 Sep; 27(3):225-35. PubMed ID: 5702439
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cuent pharmacological theory of anti-arrhythmia agents, with special reference to beta-receptor blockaders].
    Takenaka F; Takeya N
    Nihon Rinsho; 1969 Oct; 27(10):2470-8. PubMed ID: 4390982
    [No Abstract]   [Full Text] [Related]  

  • 25. [Action of antiarrhythmic and -receptor blocking drugs on functional refractory period and contractility of electrically stimulated guinea-pig atria].
    Reuter N; Heeg E
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(3):323-33. PubMed ID: 4402232
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental study of the anti-arrhythmic activity of some beta-blocking drugs].
    Arcangeli A; Sarcinelli L; Brusadelli S
    Acta Anaesthesiol; 1968; ():Suppl 8:335+. PubMed ID: 4393552
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-fibrillary and anti-adrenaline activity of beta-receptor blocking drugs.
    Raper C; Jowett A
    Eur J Pharmacol; 1967 Sep; 1(5):353-62. PubMed ID: 4385120
    [No Abstract]   [Full Text] [Related]  

  • 28. Bamethan A competitive betamimetic drug.
    Marmo E; Saini RK; Caputi AP
    Res Commun Chem Pathol Pharmacol; 1974 Jun; 8(2):247-72. PubMed ID: 4152789
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of beta adrenergic receptor blockade on skeletal muscle vasodilatation produced by isoxsuprine and nylidrin.
    Manley ES; Lawson JW
    Arch Int Pharmacodyn Ther; 1968 Sep; 175(1):239-50. PubMed ID: 4387239
    [No Abstract]   [Full Text] [Related]  

  • 30. [Beta-adrenolytic drugs, coronary flow and pitressin-inducdd electroencephalgraphic changes].
    Marmo E; Coscia L; Aulisio GA
    Clin Ter; 1966 Oct; 39(2):137-59. PubMed ID: 4385208
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the action mechanism of new coronary dilators with simultaneous oxygen saving myocardial effects, Prenylamine and Iproveratril. 1].
    Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
    Z Kreislaufforsch; 1967 Jul; 56(7):716-44. PubMed ID: 5592004
    [No Abstract]   [Full Text] [Related]  

  • 32. [The relationship of cardiodepressive and adrenolytic effects of various beta-receptor blocking agents on dog heart-lung preparations].
    Schmidt HD; Schmier J
    Klin Wochenschr; 1967 Jul; 45(13):688-90. PubMed ID: 5589240
    [No Abstract]   [Full Text] [Related]  

  • 33. [Selective inhibition of myocardial contractility by competitive divalent Ca++ antagonists (iproveratril, D 600, prenylamine)].
    Fleckenstein A; Tritthart H; Fleckenstein B; Herbst A; Grün G
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):227-8. PubMed ID: 4242380
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experimental analysis of the effects of PGE2 on uterine, intestinal and cardiac musculature and on striated muscle].
    Lampa E; Rosatti F; Imperatore A; Magliulo S; Giasi M; Spaziante G; Di Mezza G; Marmo E
    Arch Ostet Ginecol; 1979; 84(3-4):151-84. PubMed ID: 317990
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 36. [Sympatholytic ("antisympathotonic") substances].
    Kruger K
    Minerva Med; 1968 Dec; 59(96):5227-30. PubMed ID: 5710726
    [No Abstract]   [Full Text] [Related]  

  • 37. [A new group of competitive divalent Ca-antagonists (iproveratril, D 600, prenylamine) with potent inhibitory effects on electromechanical coupling in mammalian myocardium].
    Fleckenstein A; Tritthart H; Flackenstein B; Herbst A; Grün G
    Pflugers Arch; 1969; 307(2):R25. PubMed ID: 5814829
    [No Abstract]   [Full Text] [Related]  

  • 38. [Beta-adrenolytics, coronary flow, frequency and width of heart contractions].
    Marmo E; Coscia L; Matera A
    Cardiologia (Basel); 1968; 52(4):177-89. PubMed ID: 4388771
    [No Abstract]   [Full Text] [Related]  

  • 39. Some effects of iproveratril (Isoptin) on the cardiovascular system.
    Nayler WG; McInnes I; Swann JB; Price JM; Carson V; Race D; Lowe TE
    J Pharmacol Exp Ther; 1968 Jun; 161(2):247-61. PubMed ID: 5650138
    [No Abstract]   [Full Text] [Related]  

  • 40. [Research on the mechanism of sensitization of the guinea pig uterus to oxytocin by diphenhydramine. IV. Further studies of the behavior of isolated rabbit uterus].
    Bernardi M; Bertolini A
    Boll Soc Ital Biol Sper; 1967 Jul; 43(13):787-90. PubMed ID: 4383280
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.